Pacer Advisors
OLMA icon

Pacer Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Pacer Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+1,261
New +$16.9K ﹤0.01% 2282
2024
Q3 		– Sell
-580
Closed -$6.28K – 2652
2024
Q2 		$6.28K Sell
580
-789
-58% -$8.56K ﹤0.01% 3616
2024
Q1 		$15.5K Buy
+1,369
New +$17.7K ﹤0.01% 3483

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Pacer Advisors's OLMA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 1,261 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2282 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in OLMA as recently as Q2 2024.

Pacer Advisors first reported a position in OLMA in Q1 2024 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Pacer Advisors held 1,261 shares of Olema Pharmaceuticals worth $16K as of Q2 2026.
  • Olema Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2282 holding.
  • Pacer Advisors first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.